Replies to post #33302 on Humanigen Inc (fka HGENQ)

[DonDonDonDon]

9.6% of lenz patients passed away whereas 13.9% of placebo passed away for a p value of 0.2287.

It should be noted that the current ACTIV-5 patient population of CRP<150/mg/L and <85yo had 2.17-fold efficacy on mortality in the LIVE-AIR. The ACTIV-5 trial expansion should easily attain stat sig on mortality.